Summary
Updated Aug 30, 2026
Pardeep Nijhawan is Chief Executive Officer, Director, 10% Owner of Edesa Biotech, Inc. (EDSA). 25 SEC Form 4 filings on record going back to 2024, most recently on 4 August 2026. Most recent open-market trade: bought $7K of EDSA on 10 March 2026. Lifetime open-market purchases: $230K. Historical track record: 4/5 stars across 8 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction Pardeep Nijhawan has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 8 |
| Purchases with forward-return data | 8 |
| 30-day win rate | 88% |
| 90-day win rate | 88% |
| Avg 5-day return | +112.22% |
| Avg 30-day return | +99.68% |
| Avg 90-day return | +154.99% |
| Best 30-day return | +243.87% |
Trading Pattern
InsiderAlpha's records for Pardeep Nijhawan go back to 2024: 25 primary Form 4 filings, an average of 8.3 per year. The typical open-market purchase is $29K (8 buys totaling $230K). The largest single buy on record is $67K of EDSA in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Pardeep Nijhawan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael J. Brooks - $3K of EDSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pardeep Nijhawan?
Pardeep Nijhawan is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of Edesa Biotech, Inc. (EDSA). InsiderAlpha holds 25 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pardeep Nijhawan submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Pardeep Nijhawan been buying or selling stock?
Recorded transactions: 8 open-market purchases ($230K) and 0 open-market sales across all tracked filings.
How accurate is Pardeep Nijhawan's historical track record?
Across 8 tracked purchases, Pardeep Nijhawan averaged +99.7% avg 30-day return with a 88% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Pardeep Nijhawan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pardeep Nijhawan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial